Table 5.
Study | Intervention | Cognitive Domains | Ref | ||||
---|---|---|---|---|---|---|---|
Cognitive Deterioration | Memory | Attention | Fluency | Executive Function | |||
Valls-Pedret et al., 2012 | Total OO | ● | ● | ● | ● | ● | [69] |
Virgin OO | ● | ● | ● | ● | ● | ||
Martínez-Lapiscina et al., 2013 | EVOO | ● | ● | ● | ● | ● | [70] |
Martínez-Lapiscina et al., 2013 | EVOO | ● | ● | ● | ● | ● | [71] |
Valls-Pedret et al., 2015 | EVOO | ● | ● | ● | ● | ● | [72] |
Mazza et al., 2018 | EVOO | ● | ● | ● | ● | ● | [77] |
Tsolaki et al., 2020 | HP-EVOO | ● | ● | ● | ● | ● | [73] |
MP-EVOO | ● | ● | ● | ● | ● | ||
Nishi et al., 2021 | Total OO | ● | ● | ● | ● | ● | [4] |
Kaddoumi et al., 2022 | EVOO | ● | ● | ● | ● | ● | [74] |
Marianetti et al., 2022 | Oleuropein | ● | ● | ● | ● | ● | [75] |
Green: significant results; Grey: not evaluated; Yellow: evaluated but no significant results were observed. Cognitive domains were classified as follows: cognitive deterioration (MMSE, CDT, ADAS-Cog), memory (RAVLT, ROCF and WMS-IV), attention (Digit forward test), fluency (FAS, animal and letter fluency) and executive function (ROCF, tests assessing working memory).